| Dr Adam Ryan Schweim, PHARMD | |
|
1020 Johnson Blvd, South Lake Tahoe, CA 96150-8214 | |
| (530) 542-7744 | |
| (530) 542-7750 |
| Full Name | Dr Adam Ryan Schweim |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1020 Johnson Blvd, South Lake Tahoe, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649572892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 59127 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Ryan Schweim, PHARMD 1020 Johnson Blvd, South Lake Tahoe, CA 96150-8214 Ph: (530) 542-7744 | Dr Adam Ryan Schweim, PHARMD 1020 Johnson Blvd, South Lake Tahoe, CA 96150-8214 Ph: (530) 542-7744 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Gov. Rod Blagojevich of Illinois has had a legal complaint demanding nearly $2.6 million filed against him by a British wholesaler Ecosse Hospital Products Ltd. for 254,250 doses of a flu vaccine ordered by Blagojevich to provide thousands of flu vaccine doses for Illinois.
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.
Sucampo Pharmaceuticals, Inc. today announced that its subsidiary, Sucampo Pharma, Ltd., has initiated enrollment and completed the randomization of the first patient into the pivotal phase 3 efficacy trial of lubiprostone for chronic idiopathic constipation (CIC) in Japan.
› Verified 8 days ago
Maria Chiaro, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1222 Gold Dust Trail, South Lake Tahoe, CA 96151 Phone: 412-360-3393 | |
Mr. Garnet Carlson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1040 Emerald Bay Rd, South Lake Tahoe, CA 96150 Phone: 530-541-5230 Fax: 530-541-8264 | |
Douglas William Mundy, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2074 Lake Tahoe Blvd Ste 1, South Lake Tahoe, CA 96150 Phone: 530-541-0870 Fax: 530-541-0884 | |
Dr. Anh T Ngo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1043 Emerald Bay Rd, South Lake Tahoe, CA 96150 Phone: 916-297-2040 | |
Tamara Riggs, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1020 Al Tahoe Blvd, South Lake Tahoe, CA 96150 Phone: 530-541-2530 | |
Dr. Kevin Jason Gregerson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3471 Lake Tahoe Blvd, South Lake Tahoe, CA 96150 Phone: 530-541-9477 | |
Miss Joanna Malgorzata Puszka, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1043 Emerald Bay Rd, South Lake Tahoe, CA 96150 Phone: 303-621-5831 |